Trends in gynaecologic cancer mortality and the impact of the COVID-19 pandemic in the United States

Table 1 Age characteristics of gynaecologic cancer deaths in the U.S., 2010–2022

		2010–2022	2010	2019	2020	2021	2022
Gynecologic Cancer†	Overall	334,382 [100.00]	23,937 [100.00]	26,649 [100.00]	27,969 [100.00]	28,154 [100.00]	28,017 [100.00]
	Age
	25–44	17,367 [5.19]	1279 [5.34]	1315 [4.93]	1397 [4.99]	1540 [5.47]	1361 [4.86]
	45–64	106,225 [31.77]	8042 [33.60]	8093 [30.37]	8331 [29.79]	8220 [29.20]	8121 [28.99]
	≥ 65	210,790 [63.04]	14,616 [61.06]	17,241 [64.70]	18,241 [65.22]	18,394 [65.33]	18,535 [66.16]
Ovarian Cancer	Overall	195,885 [100.00]	15,548 [100.00]	14,570 [100.00]	14,822 [100.00]	14,807 [100.00]	14,597 [100.00]
	Age
	25–44	5547 [2.83]	464 [2.98]	407 [2.79]	416 [2.81]	424 [2.86]	433 [2.97]
	45–64	58,481 [29.85]	4829 [31.06]	4193 [28.78]	4240 [28.61]	4119 [27.82]	4110 [28.16]
	≥ 65	131,857 [67.31]	10,255 [65.96]	9970 [68.43]	10,166 [68.59]	10,264 [69.32]	10,054 [68.88]
Cervical Cancer	Overall	60,540 [100.00]	4346 [100.00]	4673 [100.00]	4905 [100.00]	5075 [100.00]	4772 [100.00]
	Age
	25–44	10,376 [17.14]	744 [17.12]	768 [16.43]	845 [17.23]	944 [18.60]	775 [16.24]
	45–64	26,722 [44.14]	2033 [46.78]	2038 [43.61]	2067 [42.14]	2095 [41.28]	1987 [41.64]
	≥ 65	23,442 [38.72]	1569 [36.10]	1867 [39.95]	1993 [40.63]	2036 [40.12]	2010 [42.12]
Uterine Corpus Cancer	Overall	79,143 [100.00]	4119 [100.00]	7506 [100.00]	8349 [100.00]	8393 [100.00]	8787 [100.00]
	Age
	25–44	1507 [1.90]	74 [1.80]	141 [1.88]	139 [1.66]	187 [2.23]	158 [1.80]
	45–64	21,488 [27.15]	1207 [29.30]	1894 [25.23]	2067 [24.76]	2047 [24.39]	2076 [23.63]
	≥ 65	56,148 [70.94]	2838 [68.90]	5471 [72.89]	6143 [73.58]	6159 [73.38]	6553 [74.58]

Data are presented as n [%]; age is presented in years. †Gynaecologic cancer includes cervix uteri (International Statistical Classification of Disease and Related Health Problems, 10th revision [ICD-10] code C53), corpus uteri (ICD-10 code C54), and ovary (ICD-10 code C56)

ISSN: 1750-9378